|
1-888-999-4774 OMNISENSE 7000S/8000S
|
|
Monitoring Response To Treatment
Different bones respond to treatment at varying rates
and degrees. Using multi-site measurements, the physician can identify and
monitor small bone changes in a relatively short period of time, allowing
more effective monitoring and treatment decisions.
For further reading on the advantages of multi-site measurements, please
refer to the following abstracts:
Does
Combining the Results from Multiple Bone Sites measured by a New
Quantitative Ultrasound Device Improve Discrimination of Hip Fracture?
D. Hans et. al.
Multiple
Site Ultrasound Measurements Predict Vertebral Fractures in Postmenopausal
Women
K.M. Knapp, et. al.
Discrimination
Between Hip Fracture and Age-Matched Controls Using a Commercialized
Multi-Site Quantitative Ultrasound Device
D. Hans, et. al.
Thyroid
Dysfunctional State Detected by QUS Measurement at Multiple Skeletal Sites
A. Ben-Shlomo, et. al.
Click here to
return to the Omnisense 8000S product page
|
Message from the MEC/OBD
president:"As president, I have committed my company to providing medical facilities with "state-of-the-art" bone densitometry equipment to help them do a better job with preventing, testing for, screening for, detecting, diagnosing, and treating Osteoporosis which ravage so many women and men. Our diagnostic equipment will speed up the prevention, detection, diagnosis, and treatment of Osteoporosis and osteoporotic bone disorders in men and women. The key to preventing Osteoporosis in women and men is early detection, diagnosis, and treatment. This means measuring, testing, screening, detecting, and diagnosing low bone mass in women and men early in their lifetimes so that effective treatment can stop the Osteoporosis dead in its tracks." Together, we can help protect families from this terrible disease. Sincerely, |
MEC/OBD websites are managed by Online Design & Technology in accordance with MEC/OBD & Technology agreement #053198.